Philip G. Murphy

3.1k total citations
87 papers, 2.2k citations indexed

About

Philip G. Murphy is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Philip G. Murphy has authored 87 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 23 papers in Infectious Diseases and 18 papers in Molecular Biology. Recurrent topics in Philip G. Murphy's work include Cystic Fibrosis Research Advances (26 papers), Salmonella and Campylobacter epidemiology (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Philip G. Murphy is often cited by papers focused on Cystic Fibrosis Research Advances (26 papers), Salmonella and Campylobacter epidemiology (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). Philip G. Murphy collaborates with scholars based in Ireland, United Kingdom and United States. Philip G. Murphy's co-authors include John E. Moore, Catherine M. Greene, Noel G. McElvaney, Siobhán McClean, M. Callaghan, Shane O’Neill, Clifford C. Taggart, Emma Caraher, J.S. Elborn and Paul McNally and has published in prestigious journals such as Nature, The Journal of Immunology and PLoS ONE.

In The Last Decade

Philip G. Murphy

85 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip G. Murphy Ireland	29	663	476	445	411	270	87	2.2k
Amit Kumar Verma India	29	566 0.9×	441 0.9×	473 1.1×	377 0.9×	79 0.3×	165	2.9k
Francesca Berlutti Italy	32	258 0.4×	726 1.5×	414 0.9×	202 0.5×	90 0.3×	82	2.7k
Chyi‐Liang Chen Taiwan	28	222 0.3×	618 1.3×	476 1.1×	681 1.7×	576 2.1×	150	2.5k
Steffen Engelhart Germany	25	267 0.4×	223 0.5×	561 1.3×	478 1.2×	280 1.0×	77	1.9k
Eric J. Hansen United States	36	253 0.4×	822 1.7×	426 1.0×	1.3k 3.2×	386 1.4×	96	3.5k
S M Finegold United States	29	287 0.4×	607 1.3×	829 1.9×	478 1.2×	140 0.5×	61	2.5k
Jagdish Chander India	32	449 0.7×	277 0.6×	1.2k 2.7×	867 2.1×	341 1.3×	208	3.4k
Maria Rosaria Catania Italy	28	257 0.4×	649 1.4×	470 1.1×	462 1.1×	275 1.0×	93	2.3k
Shaan L. Gellatly Australia	19	693 1.0×	2.7k 5.7×	578 1.3×	372 0.9×	534 2.0×	22	4.4k
Thomas M. Reid United Kingdom	30	173 0.3×	762 1.6×	740 1.7×	263 0.6×	98 0.4×	83	3.0k

Countries citing papers authored by Philip G. Murphy

Since Specialization

Citations

This map shows the geographic impact of Philip G. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Murphy more than expected).

Fields of papers citing papers by Philip G. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Murphy. The network helps show where Philip G. Murphy may publish in the future.

Co-authorship network of co-authors of Philip G. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Murphy. A scholar is included among the top collaborators of Philip G. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Murphy. Philip G. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dunne, Katie, Siobhán McClean, Seán Doyle, et al.. (2023). Aspergillus fumigatus Supernatants Disrupt Bronchial Epithelial Monolayers: Potential Role for Enhanced Invasion in Cystic Fibrosis. Journal of Fungi. 9(4). 490–490. 3 indexed citations

Kapoor, Priya & Philip G. Murphy. (2018). Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics. Heliyon. 4(3). e00562–e00562. 11 indexed citations

Mirković, Bojana, Gillian Lavelle, Ahmed Abdul Azim, et al.. (2015). The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis. Journal of Allergy and Clinical Immunology. 137(2). 436–443.e9. 42 indexed citations

Wagner, Karen, Joanne White, Shona Neal, et al.. (2013). Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007-2008: a multicentre European study. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 6 indexed citations

Chotirmall, Sanjay H., J. A. A. Renwick, Tidi Hassan, et al.. (2012). The Effect of Aspergillus fumigatus Infection on Vitamin D Receptor Expression in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(10). 999–1007. 83 indexed citations

McNally, Paul, Gudmundur Bergsson, Clifford C. Taggart, et al.. (2011). Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. Journal of Cystic Fibrosis. 10(6). 428–434. 48 indexed citations

Fraher, Marianne, Karen O’Connell, Jérôme Fennell, et al.. (2011). Reporting of meticillin-resistant and -susceptible Staphylococcus aureus on death certificates in Irish hospitals. Journal of Hospital Infection. 77(2). 143–147. 2 indexed citations

Wagner, Karen, Joanne White, Shona Neal, et al.. (2010). Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007–2008: a multicentre European study. Clinical Microbiology and Infection. 17(4). 519–525. 38 indexed citations

Bergsson, Gudmundur, Emer P. Reeves, Paul McNally, et al.. (2009). LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline. The Journal of Immunology. 183(1). 543–551. 110 indexed citations

10.

Caraher, Emma, et al.. (2007). The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. Journal of Antimicrobial Chemotherapy. 60(3). 546–554. 24 indexed citations

11.

Rogan, Mark P., Clifford C. Taggart, Catherine M. Greene, et al.. (2004). Loss of Microbicidal Activity and Increased Formation of Biofilm Due to Decreased Lactoferrin Activity in Patients with Cystic Fibrosis. The Journal of Infectious Diseases. 190(7). 1245–1253. 136 indexed citations

12.

Xu, Jiru, John E. Moore, Philip G. Murphy, B. Cherie Millar, & J.S. Elborn. (2004). Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Annals of Clinical Microbiology and Antimicrobials. 3(1). 21–21. 78 indexed citations

13.

Millar, B. Cherie, Jianguo Xu, Angelica Moran, et al.. (2003). Haemophilus segnis: a rare cause of endocarditis. Clinical Microbiology and Infection. 9(10). 1048–1050. 13 indexed citations

14.

Moore, John E., Janet A. Buchanan, D.F. Gilpin, et al.. (2002). Occurrence ofBurkholderia cepacia in the hospital environment. Irish Journal of Medical Science (1971 -). 171(3). 131–133. 2 indexed citations

15.

Moore, John E., Thomas S. Wilson, D.R.A. Wareing, T. J. Humphrey, & Philip G. Murphy. (2002). Prevalence of Thermophilic Campylobacter spp. in Ready-to-Eat Foods and Raw Poultry in Northern Ireland. Journal of Food Protection. 65(8). 1326–1328. 42 indexed citations

16.

Moore, John E., Martin D. Curran, D.R.A. Wareing, et al.. (2001). Investigation of infection with Campylobacter jejuni in a man with hypogammaglobulinaemia using PCR-single-strandedconformational polymorphism (PCR-SSCP) typing. International Journal of Medical Microbiology. 291(1). 21–25. 8 indexed citations

17.

Wright, Ralph, John E. Moore, K Dunbar, et al.. (2001). Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. Journal of Clinical Pathology. 54(10). 803–805. 15 indexed citations

18.

Mallon, Patrick, et al.. (2000). Molecular identification of Acinetobacter sp. in a patient with culture-negative endocarditis. Clinical Microbiology and Infection. 6(5). 277–278. 8 indexed citations

19.

Kerr, Jonathan R., Martin D. Curran, John E. Moore, & Philip G. Murphy. (1995). Parvovirus B19 Infection - Persistence and Genetic Variation. Scandinavian Journal of Infectious Diseases. 27(6). 551–557. 24 indexed citations

20.

Murphy, Philip G.. (1970). Effects of salinity on uptake of DDT, DDE and ODD by fish. Bulletin of Environmental Contamination and Toxicology. 5(5). 404–407. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact